Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration

Acta Ophthalmologica

Volumn 88, Issue 6, 2010, Pages 630-634

  Jonas, Jost B ^a   Libondi, Teodosio ^b   Golubkina, Lidia ^a   Spandau, Ulrich H ^a   Schlichtenbrede, Frank ^a   Rensch, Florian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Avastin; exudative age related macular degeneration; intraocular anti angiogenesis; intravitreal bevacizumab; intravitreal steroids; intravitreal triamcinolone

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

ARTICLE; CLINICAL ARTICLE; HUMAN; INTRAOCULAR PRESSURE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT RESPONSE; VISUAL ACUITY;

EID: 77956214077     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01502.x     Document Type: Article

References (27)

1. Algvere PV, Steén B, Seregard S Kvanta A (2008 A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Acta Ophthalmol 86 : 482 489.
2. Bakri SJ Ekdawi NS (2008 Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation. Eye 22 : 978 980.
3. Colucciello M (2008 Intravitreal bevacizumab and triamcinolone acetonide combination therapy for exudative neovascular age-related macular degeneration: short-term optical coherence tomography results. J Ocul Pharmacol Ther 24 : 15 24.
4. Cruess AF, Zlateva G, Pleil AM Wirostko B (2009 Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties. Acta Ophthalmol 87 : 118 132.
5. Danis RP, Ciulla TA, Pratt LM Aniker W (2000 Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20 : 244 250.
6. Frimpong-Boateng A, Bunse A, Rüfer F Roider J (2009 Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients. Acta Ophthalmol 87 : 183 187.
7. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P Billson F (2003 A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: 1-year results. Arch Ophthalmol 121 : 667 673.
8. Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M, Guyer DR VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004 Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 : 2805 2816.
9. Jonas JB Söfker A (2001 Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular oedema. Am J Ophthalmol 132 : 425 427.
10. Jonas JB, Kreissig I, Söfker A Degenring RF (2003a Intravitreal injection of triamcinolone acetonide for diabetic macular oedema. Arch Ophthalmol 121 : 57 61.
11. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S Degenring R (2003b Intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Br J Ophthalmol 87 : 462 468.
12. Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U Kamppeter BA (2005 Inter-eye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 139 : 1073 1079.
13. Jonas JB, Libondi T, Ihloff AK, Harder B, Kreissig I, Schlichtenbrede F, Sauder G Spandau UH (2007 Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type. Acta Ophthalmol 85 : 563 565.
14. Jonas JB, Ihloff AK, Harder B, Kreissig I, Schlichtenbrede F, Libondi T, Spandau UH Vossmerbaeumer U (2009 Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration. Ophthalmic Res 41 : 21 27.
15. Kvanta A, Shen WY, Sarman S, Seregard S, Steen B Rakoczy E (2000 Matrix metalloproteinases (MMP) expresssion in experimental choroidal neovascularization. Curr Eye Res 21 : 684 690.
16. Penfold PL, Gyory JF, Hunyor AB Billson FA (1995 Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust N Z J Ophthalmol 23 : 293 298.
17. Rechtman E, Danis RP, Pratt LM Harris A (2004 Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Br J Ophthalmol 88 : 344 347.
18. Rich RM, Rosenfeld PJ, Puliafito CA et al. (2006 Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26 : 495 511.
19. Rosenfeld PJ, Moshfeghi AA Puliafito CA (2005 Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36 : 331 335.
20. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY MARINA Study Group (2006 Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 : 1419 1431.
21. Schmidt-Erfurth UM, Richard G, Augustin A et al. (2007 Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol 85 : 486 494.
22. Spaide RF, Sorenson J Maranan L (2005 Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112 : 301 304.
23. Spaide RF, Laud K, Fine HF et al. (2006 Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26 : 383 390.
24. Spandau U, Sauder G, Schubert U, Hammes HP Jonas JB (2005 Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo. Br J Ophthalmol 89 : 745 747.
25. Steen B, Sejersen S, Berglin L, Seregard S Kvanta A (1998 Matrix metalloproteinases and metalloproteinase inhibitor in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 39 : 2194 2200.
26. Sutter FK, Simpson JM Gillies MC (2004 Intravitreal triamcinolone for diabetic macular oedema that persists after laser treatment: 3-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111 : 2044 2049.
27. Virgili G, Do DV, Bressler NM Menchini U (2007 New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence. Acta Ophthalmol 85 : 6 20.